AP

Advisor Partners Portfolio holdings

AUM $1.42B Turnover 13.49%
1-Year Est. Return 3.97%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
-3.97%
3 Year Est. Return
+63.81%
5 Year Est. Return
+114.27%
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$92.6M
Cap. Flow
+$1.66M
Cap. Flow %
0.14%
Top 10 Hldgs %
26.4%
Holding
723
New
39
Increased
345
Reduced
308
Closed
24
Avg Time Held
3.2 years
Top 10 Avg Time Held
3.1 years
Top 20 Avg Time Held
3.2 years

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.3M
2
PFE icon
Pfizer
PFE
+$1.05M
3
IX icon
ORIX
IX
+$728K
4
PBCT
People's United Financial Inc
PBCT
+$691K
5
ED icon
Consolidated Edison
ED
+$627K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.44M
2
GILD icon
Gilead Sciences
GILD
+$1.42M
3
C icon
Citigroup
C
+$1.29M
4
INTC icon
Intel
INTC
+$1.27M
5
CSCO icon
Cisco
CSCO
+$1.27M

Sector Composition

Rank Sector Weight
1 Technology 24.51%
2 Healthcare 14.63%
3 Financials 13.76%
4 Consumer Discretionary 10.63%
5 Communication Services 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PRU icon
101
Prudential Financial
PRU
$39.2B
$2.24M 0.19%
35,276
-73
-0.2% -$4.8K
2013 Q2
29 quarters
MS icon
102
Morgan Stanley
MS
$285B
$2.23M 0.19%
46,046
+381
+0.8% +$19.2K
2013 Q2
29 quarters
AZN icon
103
AstraZeneca
AZN
$251B
$2.16M 0.19%
19,724
+1,065
+6% +$118K
2017 Q4
11 quarters
NOC icon
104
Northrop Grumman
NOC
$70.4B
$2.15M 0.18%
6,801
-148
-2% -$48.3K
2013 Q2
29 quarters
EQIX icon
105
Equinix
EQIX
$98.3B
$2.14M 0.18%
2,820
+36
+1% +$27.2K
2015 Q4
19 quarters
CME icon
106
CME Group
CME
$103B
$2.09M 0.18%
12,508
+928
+8% +$156K
2014 Q4
23 quarters
LHX icon
107
L3Harris
LHX
$44.2B
$2.09M 0.18%
12,306
-159
-1% -$27.9K
2016 Q4
15 quarters
BIIB icon
108
Biogen
BIIB
$34.4B
$2.08M 0.18%
7,349
-30
-0.4% -$8.37K
2013 Q2
29 quarters
VRTX icon
109
Vertex Pharmaceuticals
VRTX
$126B
$2.07M 0.18%
7,609
-201
-3% -$55.5K
2016 Q2
17 quarters
TJX icon
110
TJX Companies
TJX
$157B
$2.06M 0.18%
37,069
+1,094
+3% +$59K
2013 Q2
29 quarters
BDX icon
111
Becton Dickinson
BDX
$51.5B
$2.04M 0.17%
8,963
-631
-7% -$155K
2014 Q1
26 quarters
GILD icon
112
Gilead Sciences
GILD
$190B
$2.03M 0.17%
32,080
-20,545
-39% -$1.42M
2013 Q2
29 quarters
ASML icon
113
ASML
ASML
$634B
$2.02M 0.17%
5,481
+143
+3% +$53.5K
2017 Q4
11 quarters
PGR icon
114
Progressive
PGR
$124B
$2M 0.17%
21,080
+129
+0.6% +$11.6K
2015 Q3
20 quarters
PNC icon
115
PNC Financial Services
PNC
$86.1B
$1.98M 0.17%
18,005
+347
+2% +$37.3K
2013 Q2
29 quarters
SO icon
116
Southern Company
SO
$103B
$1.97M 0.17%
36,346
-2,646
-7% -$141K
2013 Q2
29 quarters
EW icon
117
Edwards Lifesciences
EW
$49.8B
$1.97M 0.17%
24,667
+3,038
+14% +$237K
2014 Q4
23 quarters
WY icon
118
Weyerhaeuser
WY
$13.6B
$1.96M 0.17%
68,616
-892
-1% -$24.5K
2016 Q4
15 quarters
CI icon
119
Cigna
CI
$76.5B
$1.95M 0.17%
11,517
-2,656
-19% -$467K
2014 Q2
25 quarters
SYK icon
120
Stryker
SYK
$108B
$1.95M 0.17%
9,334
+273
+3% +$53.1K
2014 Q4
23 quarters
ADP icon
121
Automatic Data Processing
ADP
$111B
$1.94M 0.17%
13,885
+74
+0.5% +$10.4K
2013 Q2
29 quarters
ISRG icon
122
Intuitive Surgical
ISRG
$148B
$1.93M 0.17%
8,166
-66
-0.8% -$14.8K
2015 Q4
19 quarters
NVO icon
123
Novo Nordisk
NVO
$168B
$1.93M 0.17%
55,636
+1,858
+3% +$61.9K
2017 Q3
12 quarters
AON icon
124
Aon
AON
$58.4B
$1.92M 0.16%
9,316
-291
-3% -$58.1K
2014 Q2
25 quarters
BKNG icon
125
Booking.com
BKNG
$121B
$1.92M 0.16%
28,025
-475
-2% -$33.4K
2013 Q2
29 quarters
3 4
5
6 7

Similar funds

AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.44% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

Advisor Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Advisor Partners held 723 positions worth $1.17B, up 8.6% from $1.07B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Advisor Partners's Q3 2020 filing shows 39 new, 345 increased, 308 reduced and 24 closed positions. Its largest new stake was ORIX: 59,180 shares worth $741K. The largest sale was Apple, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Advisor Partners's largest Q3 2020 buy was ORIX: 59,180 shares worth $741K.
  • Advisor Partners added most to Berkshire Hathaway Class B in Q3 2020, an estimated $1.3M increase.
  • Advisor Partners's biggest Q3 2020 reduction was Apple, cutting an estimated $1.44M.
  • Advisor Partners fully exited Barnes Group Inc. in Q3 2020, selling an estimated $345K.
  • Advisor Partners's ten largest holdings make up 26% of its $1.17B portfolio in Q3 2020.
  • Advisor Partners opened 39 new positions and closed 24 in Q3 2020.
  • Advisor Partners's portfolio value rose 8.6% quarter-over-quarter to $1.17B.

Based on Advisor Partners's 13F filing for Q3 2020, filed 5 Nov 2020.